CLINICAL_TRIALS
research
· 2025-05-04
Clinical Trial Update: Autologous Dendritic Cell Vaccine in Kidney Cancer [Phase 2]
Summary
A Phase 2 trial evaluating an autologous dendritic cell vaccine for renal cell carcinoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jodi Maranchie | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: RECRUITING